Yujia Chi

407 total citations
20 papers, 209 citations indexed

About

Yujia Chi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yujia Chi has authored 20 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Yujia Chi's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Yujia Chi is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Yujia Chi collaborates with scholars based in China, Ethiopia and United States. Yujia Chi's co-authors include Minglei Zhuo, Ziping Wang, Jianjie Li, Tongtong An, Xue Yang, Jun Zhao, Meina Wu, Jia Zhong, Xiaoyu Zhai and Hanxiao Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and BMC Cancer.

In The Last Decade

Yujia Chi

19 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujia Chi China 11 125 110 41 39 21 20 209
Ying Cheng China 8 102 0.8× 211 1.9× 64 1.6× 59 1.5× 31 1.5× 48 269
Margaux Geier France 8 150 1.2× 167 1.5× 23 0.6× 26 0.7× 18 0.9× 41 220
Jennifer Borowsky Australia 8 41 0.3× 108 1.0× 36 0.9× 23 0.6× 12 0.6× 10 174
Silvana Acquafredda Italy 6 94 0.8× 159 1.4× 42 1.0× 20 0.5× 43 2.0× 8 237
M. Dómine Gómez Spain 9 128 1.0× 210 1.9× 73 1.8× 37 0.9× 52 2.5× 36 277
Mei Xie China 11 99 0.8× 100 0.9× 93 2.3× 16 0.4× 41 2.0× 28 251
Giuliano Palumbo Italy 7 94 0.8× 165 1.5× 85 2.1× 75 1.9× 11 0.5× 15 244
Rocco Giannicola Italy 8 62 0.5× 99 0.9× 34 0.8× 13 0.3× 29 1.4× 16 196
David Dum Germany 6 42 0.3× 55 0.5× 31 0.8× 23 0.6× 10 0.5× 16 115
Songqiang Zhou China 9 82 0.7× 107 1.0× 34 0.8× 69 1.8× 13 0.6× 15 294

Countries citing papers authored by Yujia Chi

Since Specialization
Citations

This map shows the geographic impact of Yujia Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Chi more than expected).

Fields of papers citing papers by Yujia Chi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujia Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Chi. The network helps show where Yujia Chi may publish in the future.

Co-authorship network of co-authors of Yujia Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Yujia Chi. A scholar is included among the top collaborators of Yujia Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujia Chi. Yujia Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yifan, Jun Tong, Yafang Tan, et al.. (2025). Isolation, culture, and in vitro functional validation of intratumor bacteria from lung cancer patients. BMC Microbiology. 25(1). 558–558.
2.
Kong, Ling‐Dong, Minglei Zhuo, Tongtong An, et al.. (2024). Women patients with small‐cell lung cancer using immunotherapy in a real‐world cohort achieved long‐term survival. Thoracic Cancer. 15(23). 1727–1738. 1 indexed citations
3.
Li, Junfeng, Huifeng Hao, Jia Wang, et al.. (2023). Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma. BMC Cancer. 23(1). 110–110. 11 indexed citations
4.
Guo, Xin, Jianjie Li, Jingwan Han, et al.. (2022). Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells. Frontiers in Microbiology. 13. 850444–850444. 12 indexed citations
5.
Chen, Hanxiao, Dingzhi Huang, Gen Lin, et al.. (2022). The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer. Cancer Medicine. 11(19). 3581–3592. 19 indexed citations
6.
Wang, Jingjing, Yujia Chi, Hanxiao Chen, et al.. (2022). [Analysis of the Effcacy and Safety of Amivantamab in Non-small Cell Lung Cancer 
Patients with EGFR/MET Gene Abnormalities: A Single Center's Experience].. SHILAP Revista de lepidopterología. 25(7). 493–500. 1 indexed citations
7.
Chi, Yujia, Yiliang Liu, & Jun Zhao. (2022). [Advances in Immunotherapy for Malignant Pleural Mesothelioma].. SHILAP Revista de lepidopterología. 25(4). 259–265. 1 indexed citations
8.
He, Yuling, Jingjing Wang, Ling‐Dong Kong, et al.. (2021). Clinical Characteristics of Cardiac and Pericardial Metastasis in Small Cell Lung Cancer with Arrhythmia. 5(1). 1 indexed citations
9.
Xing, Puyuan, Mengzhao Wang, Jun Zhao, et al.. (2021). Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy. Thoracic Cancer. 12(20). 2825–2828. 7 indexed citations
10.
Li, Jianjie, Yujia Chi, Guang Cao, et al.. (2021). Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting. Journal of Thoracic Disease. 13(3). 1813–1821. 6 indexed citations
11.
Jia, Bo, Qiwen Zheng, Jianjie Li, et al.. (2021). Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I–IIIA non-small cell lung cancer patients. Journal of Thoracic Disease. 13(3). 1799–1812. 4 indexed citations
12.
Wang, Yida, Tianzhuo Zhang, Xue Yang, et al.. (2021). Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients. Annals of Translational Medicine. 9(1). 33–33. 24 indexed citations
13.
Wang, Yuyan, Qiwen Zheng, Bo Jia, et al.. (2020). Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database. Frontiers in Oncology. 10. 626–626. 19 indexed citations
14.
Li, Jianjie, Qiwen Zheng, Xinghui Zhao, et al.. (2020). Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis. BMC Cancer. 20(1). 793–793. 16 indexed citations
15.
16.
Wang, Shuhang, Yujia Chi, Minglei Zhuo, et al.. (2020). Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma. Thoracic Cancer. 11(5). 1149–1159. 5 indexed citations
17.
Zhuo, Minglei, Yujia Chi, & Ziping Wang. (2020). The adverse events associated with combination immunotherapy in cancers: Challenges and chances. Asia-Pacific Journal of Clinical Oncology. 16(5). e154–e159. 12 indexed citations
18.
Zhuo, Minglei, Qiwen Zheng, Yujia Chi, et al.. (2019). Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database. Thoracic Cancer. 10(5). 1193–1202. 14 indexed citations
19.
Zhong, Jia, Qiwen Zheng, Tongtong An, et al.. (2019). Nomogram to predict cause‐specific mortality in extensive‐stage small cell lung cancer: A competing risk analysis. Thoracic Cancer. 10(9). 1788–1797. 13 indexed citations
20.
Jia, Bo, Qiwen Zheng, Jun Zhao, et al.. (2019). Survival comparison of right and left side non‐small cell lung cancer in stage I–IIIA patients: A Surveillance Epidemiology and End Results (SEER) analysis. Thoracic Cancer. 10(3). 459–471. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Margaux Geier Breakdown of academic impact, for papers by Jennifer Borowsky Breakdown of academic impact, for papers by Silvana Acquafredda Breakdown of academic impact, for papers by M. Dómine Gómez Breakdown of academic impact, for papers by Mei Xie Breakdown of academic impact, for papers by Giuliano Palumbo Breakdown of academic impact, for papers by Rocco Giannicola Breakdown of academic impact, for papers by David Dum Breakdown of academic impact, for papers by Songqiang Zhou
Rankless by CCL
2026